eFlow Technology – Partnering for pharmaceutical companies

Optimized
membrane
nebulizers

We are your nebulizer partner

for drug-device combination development

We support pharmaceutical companies or startups in achieving their objectives – to develop and market efficient nebulized therapies.

As the nebulizer is an integral part of the aerosol therapy, we contribute by developing and manufacturing optimized membrane nebulizers based on eFlow^® Technology platform. Such nebulizers are specifically tailored to certain drug formulations.

Our partners approach us because of our decades of experience in nebulizing drugs and drug-device combination development. Six marketed eFlow^® Technology nebulizers and more than 25 ongoing development projects prove our reliability during the development phase as well as commercialization and afterwards..

Learn more on these pages about how we can help you. We look forward to hearing from you.

Optimized membran nebulizers for innovative aerosol therapies

Our offer to you

Watch this video to learn about our expertise in developing and manufacturing optimized membrane nebulizers.

eFlow Technology nebulizers with digital therapy management

Learn how the PARI Connect system supports patients with carefully considered device usability and digital therapy management solutions.

YOUR innovative aerosol therapy – OUR drug-nebulizer expertise

Watch five short expert interviews containing all you need to know about our partnering approach for pharmaceutical companies.

Developing new drug-nebulizer combination products

Learn more about the critical success factors and opportunities for bringing a new vibrating membrane nebulizer as a drug-device combination product to the market.